Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|May 29, 2015
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosisTamer M Fouad, Takahiro Kogawa, Diane D Liu, et al.
Breast Cancer (Tokyo, Japan)|April 20, 2024
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational studyTetsuhiro Yoshinami, Shigenori E Nagai, Masaya Hattori, et al.
Scientific Reports|May 24, 2020
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancerMaria Gagliardi, Mary Kathryn Pitner, Jihyun Park, et al.
Oncotarget|October 6, 2017
EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancerXiaoping Wang, Monica E Reyes, Dongwei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasetsSteven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Breast Cancer (Tokyo, Japan)|February 27, 2017
Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese womenTerumasa Sawada, Sadako Akashi, Seigo Nakamura, et al.
Breast Cancer Research : BCR|November 27, 2013
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancersHiroko Masuda, Keith A Baggerly, Ying Wang, et al.
European Journal of Breast Health|September 11, 2024
Retrospective Analysis of the Clinical Usefulness of a Strut-Adjusted Volume Implant in a Single CenterArisa Ata-Shiroshita, Takashi Kuwayama, Masako Kato, et al.
Breast Cancer (Tokyo, Japan)|April 5, 2025
Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)Shigenori E Nagai, Masaya Hattori, Tetsuhiro Yoshinami, et al.
Plos One|October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtypeKenichi Harano, Ying Wang, Bora Lim, et al.
Pageof 6